Tarsus Pharmaceuticals DPO Ratio 2011-2026 | TARS

Quarterly DPO Ratio Tarsus Pharmaceuticals

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
315	-	-	-	-	-	-	-	-	-	-	-	-	-	710	9.52 K	-	3.73 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
9.52 K	315	3.57 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	5.06 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Esperion Therapeutics ESPR	7.93 K	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	74.3	$ 34.45	4.74 %	$ 927 M	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Celyad Oncology SA CYAD	55.8 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.62	-0.61 %	$ 431 M	Britain
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.79 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	82.7	$ 2.71	-0.92 %	$ 253 M	Israel
Anika Therapeutics ANIK	43.4	$ 15.14	2.16 %	$ 217 M	USA
Advaxis ADXS	85.6 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	200	$ 97.08	1.55 %	$ 19 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Coherus BioSciences CHRS	507	$ 1.51	2.03 %	$ 177 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 20.47	4.97 %	$ 2.6 B	USA
Ampio Pharmaceuticals AMPE	4.62 K	-	-11.43 %	$ 502 K	USA